case_images: PMC10619899_01
case_images: PMC10619899_02
case_images: Changes in cardiac function index levels during hospitalization (x-axis = date, y-axis = unit symbol). (A) shows the level change of CK; (B) shows the level change of Tn-I. (C) shows the level change of CK-MB.
case_images: fimmu-14-1253463-g001.jpg
case_images: PMC10619899_02_fimmu-14-1253463-g001.jpg
case_images: f1
case_images: As seen in  Figure 1 , methylprednisolone treatment effectively reduced the levels of all three markers.
case_images: PMC10619899_03
case_images: Paralysis/myasthenia gravis: an elderly female with eye movement disorder and ptosis. The symptoms of ptosis were compared between pre-intervention (A) and post-intervetion (B).
case_images: fimmu-14-1253463-g002.jpg
case_images: PMC10619899_03_fimmu-14-1253463-g002.jpg
case_images: f2
case_images: As indicated in  Figure 2 , the patient was free from symptoms of ptosis at the time of discharge.
case_images: Timeline of disease onset, progression, diagnosis, treatment, and follow-up.
case_images: fimmu-14-1253463-g003.jpg
case_images: PMC10619899_03_fimmu-14-1253463-g003.jpg
case_images: f3
case_images: During this period, there was no recurrence of immune-related adverse events (iRAEs), and the tumor did not progress significantly.  Figure 3  illustrates the primary time nodes of patients' disease occurrence, development, diagnosis, treatment, and follow-up.